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Abstract: The hematopoietic microenvironment regulates self-renewal and differentiation of hematopoietic stem cells. Mesenchymal
stromal cells (MSCs) contribute to the niche and participate in supporting dendritic cell (DC) commitment in vitro and in vivo.
However, due to MSCs being heterogenic, it is necessary to understand the function of the MSC subpopulation in modulating the
DC commitment. The current study showed that one of the bone-related Sca1+ MSCs enhanced bone marrow cell differentiation into
DCs by direct cell-to-cell contact. Furthermore, the expression of STAT3 and STAT5 genes decreased in supernatant cells after Sca1+
MSCs were cocultured with bone marrow cells. In contrast, the expression level of caspase-3 in cells increased. At the same time, the
presentation of costimulatory molecules CD80/CD86 and the migration of activated DCs towards lymph nodes were augmented by
Sca1+ MSCs. The results demonstrated that the Sca1+ MSC subpopulation promotes the differentiation of bone marrow cells into DCs by
direct cell-to-cell contact via STAT3/STAT5 and caspase-3 signaling. Meanwhile, Sca1+ MSCs also mediate the activation and migration
capabilities of DCs.
Key words: Caspase-3, development, dendritic cells, migration capability, Sca1+ mesenchymal stromal cells

1. Introduction
Dendritic cells (DCs) are essential mediators in innate and
adaptive immune responses. Except for Langerhans cells,
DCs are derived from hematopoietic stem cells (HSCs)
(Belz and Nutt, 2012; Satpathy et al., 2012; Seillet and
Belz, 2013). Evidence has shown that self-renewing or
the differentiation of HSCs, including DC commitment,
mainly occurs in the bone marrow, with a high probability
of being regulated by the hematopoietic microenvironment
(niche) (Schraml et al., 2013). However, little is known
about how the endosteal niche regulates the development
of DC progenitors in bone marrow. Mesenchymal stromal
cells (MSCs) are the most important components in the
niche (Frenette et al., 2013). Recently, Jiang et al. (2005)
reported that MSCs inhibited DC differentiation and
maturation (Spaggiari et al., 2009; Zhang et al., 2009; Lai
et al., 2010), as well as DC effector properties, including
antigen processing and presentation to T cells (Chiesa et
al., 2011).

MSCs are actually heterogenic mixtures. A recent study
reported that different subpopulations of MSCs served as
unclassical niche components in bone marrow, such as
CXCL12-abundant reticular (CAR) cells (Sugiyama et al.,
2006; Ding and Morrison, 2013), nestin+ cells (MendezFerrer et al., 2010), Mx-cre+ cells (Park et al., 2012), leptin+
receptor-expressing mesenchymal cells (Ding et al., 2012),
adipocytes (Naveiras et al., 2009), CD146+ cells, CD166+
cells (Hudson et al., 2011), and CD271+ cells (Mabuchi et
al., 2013). Sca1 is one of the MSC markers (Morikawa et
al., 2009). Many markers were used to identify in situ and/
or to isolate MSCs in mice, such as CD29, CD51, CD73,
CD90, CD105, CD106, CD135, C-KIT, nestin, PDGFRα,
and Sca1, but the lack of specific markers impedes
identification of MSC functions (Galderisi and Giordano,
2014). Previously we enzymatically dissociated bone
and separated the Sca1+ MSCs from the MSC mixture.
Previously we also checked the purity of Sca1+ MSCs after
isolation. Sca1+ MSCs were more than 80%, while CD45+,
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CD11c+, CD146+, and CD166+ cells were less than 0.5%.
The proportion of TER119+ and CD3+ cells was no more
than 0.8% (Wen et al., 2015; Chen et al., 2016a, 2016b).
Undoubtedly, niche components are instrumental to HSC
self-renewal and differentiation, but in terms of lineage
commitment, there are limited data available. For instance,
it is unclear how and which subpopulations of the niche
educate myeloid lineage progenitor-derived cells into DCs.
It is known that genes and signals are normally
cores for stem cell differentiation. Many studies have
demonstrated that the transducer and activator of
transcription 3 and 5 (STAT3 and STAT5) are important
for the development of DCs. The hematopoietic-specific
deletion of the STAT3 gene results in an acute loss of
conventional dendritic cells (cDCs) and attenuated
responses to the Fms-related tyrosine kinase 3 ligand
(Flt3L) in vivo (Laouar et al., 2003). The STAT3 signal
enhanced CD14+ DC development (Lindenberg et al.,
2013). Conversely, overexpression of STAT3 promoted DC
maturation from hematopoietic progenitors (Onai et al.,
2006). STAT5 was reported to be an important molecule
for DCs, especially for plasmacytoid dendritic cell (pDC)
development (Esashi et al., 2008). Additionally, caspase-3
played a role not only in mediating apoptosis but also in
HSC differentiation (Abdul-Ghani and Megeney, 2008;
Ding and Morrison, 2013). However, whether caspase-3 is
involved in regulating DCs is unknown.
MSCs are heterogeneous populations and may inhibit
the maturation of monocytes to myeloid DCs, but whether
bone-related Sca1+ MSC subpopulations are involved in
DC commitment is largely unknown. The present study
addresses this issue. In the current investigation, we
observed that Sca1+ MSCs enhanced the differentiation of
bone marrow cells into DCs and DC migration capability.
The STAT3, STAT5, and caspase-3 genes play a role in the
MSC-based commitment machinery in the niche. Our
investigation unveiled a special way to probe how the
niche controls the differentiation and function of DCs.
2. Materials and methods
2.1. Mice and maintenance
C57BL/6 wild-type mice were maintained by the Animal
Resource Center of the Fourth Military Medical University
under specific pathogen-free conditions. The caspase-3
knockout mice in the C57BL/6 background were from
Jackson Laboratory (Bar Harbor, ME, USA). All of
the animal treatment protocols were approved by the
Experimental Animal Committee.
2.2. Preparation of MSCs and Sca1+ MSCs
A bone-related MSC mixture and Sca1+ MSCs were isolated
using a previously described method (Wen et al., 2015;
Chen et al., 2016a, 2016b). Tibias and femurs were excised
from mice of 8–12 weeks old. After removing the muscle

and connective tissue, the bones were crushed gently with
a mortar and pestle in cold 1X PBS buffer. The crushed
mass was washed with 1X PBS to remove all of the bone
marrow cells. The remaining bone fragments were digested
with collagenase I (1 mg/mL; Sigma, Ronkonkoma, NY,
USA) at 37 °C for 1 h. The digested bones and released
cells were collected and filtered with a 40-µm strainer (BD
Bioscience, San Jose, CA, USA) and centrifuged at 200 × g
at 4 °C. The precipitate was washed twice and resuspended
in 1X PBS to get the MSC mixture. Then Sca1+ MSCs
were isolated from the MSC mixture using a mouse Sca1+
selection kit (STEMCELL Ltd., Vancouver, Canada).
2.3. Cell cultures
The bone marrow cells were collected from tibias and
femurs. The red blood cells were removed using ACK lysis
buffer (8.28 g/L NH4Cl, 1 g/L KHCO3, 37.6 g/L Na2EDTA,
pH 7.2–7.4). Bone marrow cells were cocultured with
the Sca1+ MSCs or the MSC mixture at a ratio of 10:1.
Cells were cultured in RPMI 1640, supplemented with
10% heat-inactivated fetal bovine serum (GIBCO, Life
Technologies, Grand Island, NY, USA), 5.5 × 10–5 M
β-mercaptoethanol (Sigma), and 25 mM/L HEPES
(Sigma). In some experiments, recombinant murine IL-10
(10 ng/mL; PeproTech, Rocky Hill, NJ, USA) and GM-CSF
(20 ng/mL; PeproTech) were added to the bone marrow
cells. LPS (1 µg/mL; Sigma) was added to cells for 48 h
to stimulate DC maturation. In direct cell-to-cell contact
experiments, polycarbonate transwell inserts with 0.4µm pores were used, Sca1+ MSCs cells were loaded in the
upper chamber, and the lower chamber contained bone
marrow cells (Corning Incorporated, Corning, NY, USA).
2.4. Flow cytometric analysis
The suspended and light-adherent cells were harvested and
washed twice with cold PBS. Cells were then resuspended
and stained with antibodies for 30 min on ice. After that,
flow cytometric analysis was performed with the BD
FACSCalibur (BD Biosystems). Dead cells were excluded
by 7-AAD (eBioscience, San Diego, CA, USA). The data
were analyzed using FlowJo software 7.6.1. The following
antibodies were used for the flow cytometry analysis: antiCD11C-FITC (N418, BioLegend, San Diego, CA, USA),
anti-I-A/I-E-PE (M5/114.15.2, BioLegend), anti-CD80PE (16-10A1, BD Pharmingen, San Diego, CA, USA),
anti-CD86-APC (GL1, BD Pharmingen), and isotype
antibodies.
2.5. Scanning electron microscopy
Cells grown on a coverslip were fixed in 3%
glutaraldehyde overnight at 4 °C. Cells were then routinely
osmicated and dehydrated. Samples were incubated in
hexamethyldisilazane, mounted on stubs, sputter-coated
with gold, and examined under a scanning electron
microscope (SEM, S-3400N, Hitachi, Tokyo, Japan).
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2.6. RT-PCR analysis
Total RNA was extracted from cocultured cells (the
suspended and light-adherent cells) using the RNeasy
Mini Kit (QIAGEN, Dusseldorf, Germany) and cDNA
was synthesized using Prime Script RT Master Mix
(TaKaRa, Kusatsu, Japan) following the instructions
of the supplier. Values for genes were normalized to
the relative quantity of β-actin mRNA in each sample.
Primers used for PCR were as follows: β-actin-F,
5’-GATCATGTTTGAGACCTTCAACACC; β-actin-R,
5’-CGTGAGGGAGAGCATAGCCC;
STAT3-F,
5’-TGGATGCGACCAACATCCTG;
STAT3-R,
5’-AATGGTATTGCTGCAGGTCG;
STAT5-F,
5’-CACGACGCGAGATTTCTCCA;
STAT5-R,
5’-ATCCGTCAACTGCTTTCGCA;
caspase-3-F,
5’-GTGGTTCATCCAGTCCCTTT; and caspase-3-R,
5’-CATGGACACAATACACGGGA.
2.7. Migration assays
In vitro migration assays were performed using
polycarbonate transwell inserts with 5-µm pores (Corning
Incorporated). Suspended cells and light-adherent cells
(5 × 105) were loaded in serum-free RPMI in the upper
chamber, and the lower chamber contained stromal cellderived factor-1α (200 ng/mL; PeproTech); after 10 h at 37
°C, migrated cells were harvested from the lower chamber
and counted.
For in vivo migration, LPS-activated cells were labeled
with 5- and 6-carboxyfluorescein diacetate succinimidyl
ester (CFSE) according to the manufacturer’s instructions
(KeyGEN BioTECH, Nan Jing, China). Equal numbers of
CFSE-labeled cells (2 × 105 each) were then injected into
the left hind footpad of C57BL/6 animals (three mice in
each group). After 4 h, lymph nodes were isolated and
numbers of CFSE+ cells were analyzed by FACSCalibur.
2.8. Statistical analyses
The data were analyzed with a two-tailed Student t-test
using GraphPad Prism 6 software. At P < 0.05, the
difference was considered statistically significant.
3. Results
3.1. Sca1+ MSCs promoted DC commitment
Previous reports have shown that MSCs regulate
the development and function of DCs. Different
subpopulations of MSCs may have different properties. To
evaluate the role of Sca1+ MSCs in the development of bone
marrow-derived DCs, we used a previously established
strategy to isolate Sca1+ MSCs (Wen et al., 2015; Chen
et al., 2016a, 2016b) and cocultured the MSC mixture or
Sca1+ MSCs with bone marrow cells in vitro and analyzed
them using flow cytometric analysis. With the stimulation
of Sca1+ MSCs, ten times the number of CD11c+ cells and
three times the number of MHCII+ cells were detected in
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cultured bone marrow cells than in those cocultured with
the MSC mixture (Figures 1A–1C). This indicated that
Sca1+ MSCs promoted bone marrow cell commitment
into DCs, leaving us to question whether this promotion
was from cell-to-cell contact or not. For this purpose, we
used a transwell chamber system and found that CD11c+
and MHCII+ cells did indeed increase during cell-to-cell
contact. Of the cultured cells, 18.6% were CD11c+ cells
with Sca1+ MSCs’ direct support, while only 7.03% of cells
were CD11c+ cells using the transwell system (Figures 1D–
1F). Taken together, these data suggest that Sca1+ MSCs
promoted DC commitment and that cell-to-cell contact
was needed for the promotion.
3.2. Sca1+ MSCs promoted dendrite formation
Forward scattering (FSC) and side scattering (SSC) were
used to characterize the size, thickness, and other surface
configurations of cells associated with flow cytometric
analysis. Wang et al. reported that Notch signaling is
essential for bone marrow-derived DC maturation through
the upregulation of CXCR4 and that the transition of SSClow
DCs into SSChigh DCs might reflect the increase of dendrite
formation (Wang et al., 2009). To test the formation of
dendrites, we cocultured the bone marrow cells with the
Sca1+ MSCs or the MSC mixture. After gating CD11c+ cells
on FSC and SSC, we found that coculturing Sca1+ MSCs
with bone marrow cells resulted in two times the number
of SSChigh DCs being generated than when cocultured
with the MSC mixture (Figures 2A and 2B). Typically,
LPS-stimulated DCs had a stellate appearance with
many dendrites. Under a scanning electron microscope,
both Sca1+ MSC- and MSC mixture-induced DCs had
an appearance of dendrite formation, but the number of
dendrites formed in Sca1+ MSC-induced cells was higher
than in MSC mixture-induced DCs (Figures 2C and 2D).
These results demonstrated that Sca1+ MSCs contributed
to the dendrite formation in DCs.
3.3. Caspase-3, STAT3, and STAT5 genes take part in DC
commitment mediated by Sca1+ MSCs
Researchers have reported the suggestion that STAT3 and
STAT5 genes regulate the development of DCs (MendezFerrer et al., 2010), while the caspase-3 gene mediates
stem cell differentiation and B-lymphocyte cell maturation
(Abdul-Ghani and Megeney, 2008). To examine the
molecular mechanism of DC commitment affected by
Sca1+ MSCs, we tested the expression levels of STAT3,
STAT5, and caspase-3 by qRT-PCR. The results revealed
that the expression of STAT3 and STAT5 was significantly
reduced in supernatant cells stimulated by the Sca1+
MSCs compared to those stimulated by the MSC mixture
(Figures 3A and 3B). The opposite situation was found in
the expression of caspase-3 (Figure 3C). To further probe
the role of the caspase-3 gene in DC development, we
used caspase-3 knockout mice. The number of CD11c+/
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under direct or indirect contact with Sca1+ MSCs. E) Quantitative calculation of CD11c+ cells. F) Quantitative
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Data shown are mean ± SEM. F) FACSCalibur plots of CD11c+ MHCII+ cells from the suspended and slightly adherent
cells in a cross-culture system with GM-CSF and IL- 4.

MHCII+ cells was decreased in caspase-3 knockout mice
(Figures 3D and 3E). Whether the bone marrow or the
niche leads to the decreased number of CD11c+/MHCII+
cells is unclear, however. To investigate this issue, we
used a cross-culture system and found that the CD11c+/
MHCII+ cell ratio was nearly the same when caspase-3
knocked-out bone marrow cells were cultured with or
without wild-type Sca1+ MSCs, while the CD11c+/MHCII+
cell ratio was decreased when wild-type bone marrow cells
were cultured with the caspase-3 knocked-out Sca1+ MSCs
(Figure 3F). All together, these data suggest that caspase-3,
STAT3, and STAT5 were involved in DC commitment.
3.4. Sca1+ MSCs promoted DC activation
DC activation could be triggered by LPS presenting a
higher percentage of CD80+ and CD86+ cells (Wang et al.,
2009). In this study, LPS was administered to stimulate
bone marrow-derived DCs, which were induced by GMCSF/IL-4 (positive control), the MSC mixture, or Sca1+
MSCs. Flow cytometry analysis showed that the number
of both CD80+ cells and CD86+ cells increased in the
MSC/BM and Sca1/BM groups, although they were much
lower than in the positive control group (Figures 4A–4C).
Additionally, the percentage of CD80+ cells and CD86+
cells was significantly higher in the Sca1+ group (CD80+ =
13.7%, CD86+ = 7.42%) than in the MSC group (CD80+ =
0.58%, CD86+ = 0.87%).
3.5. Sca1+ MSCs contribute to DC migration
DC migration is important for presenting antigens to T
cells (Hammer and Ma, 2013). We hypothesized that the
migration of DCs to the second lymphoid tissues could
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be impacted by Sca1+ MSCs. To examine this issue, we
tested the migration capability of DCs in vitro and in vivo
(Figures 4D and 4E). In transwell assays, we found that the
number of migrated cells was significantly increased in the
Sca1 group compared to the MSC group (Figure 4E). To
further confirm the DC migration changes introduced by
either Sca1+ MSCs or the MSC mixture, we performed an
in vivo assay. Cells were cocultured for 10 days and then
stained by CFSE before footpad injection. Six hours later,
we observed more CFSE cells in the lymphoid node in
the Sca1+ group than in the MSC group (Figures 4D and
4F). Taken together, these data demonstrate that boneassociated Sca1+ MSCs contribute to DC migration.
4. Discussion
In this context, we suggest that the Sca1+ MSCs modulate
the DC commitment. The results indicate that Sca1+ MSCs
promote DC commitment via the caspase-3, STAT3, and
STAT5 genes. Furthermore, Sca1+ MSCs alter the DCs’
migration and activation. These results demonstrate
the support of niche components for bone marrow cells
differentiating into DCs.
Although it has long been recognized that the niche
regulates self-renewal and differentiation of HSCs
(Morrison and Scadden, 2014), little was known about
how the niche regulates myeloid lineage commitment.
Studies show that MSCs inhibit the initial differentiation
of monocytes to DCs and induce mature DCs into a
regulatory DCs population (Jiang et al., 2005). Researchers
have shown that MSCs also inhibit T-cell proliferation
(Chiesa et al., 2011). MSCs are heterogeneous cells

LI et al. / Turk J Biol
A

GM-CSF+IL-4

MSC
0.87

Sca1
7.42

GM-CSF+IL-4

MSC
43.8

0.58

13.7

SSC

43.4

Sca1

D

40

Ctrl

Blank

**

30

GM-CSF+IL-4

Sca1

MSC

45.8

4.24

Count

50

positive cells(% )

CD80

CD86

B

29.8

46.2

67.3

20
10

Sc
a1

SC
M

CFSE

G
M

5

3
2
1

G
M

Sc
a1

-C
SF
+I
L4

M

SC

0

M

Sc
a1

M

SC

0

G

M

-C
SF
+I
L4

0

10

* * *

4

Sc
a1

10

15

5

-C
SF
+I
L4

20

20

SC

30

LN-arriving
CFSE+ Cells (�103)

Migration % input

*

* *

C
tr
l

positive cells(% )

25

40

G

F

E

50

M

C

C
tr
l

-C
SF
+I
L4

0
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whose subpopulation may impose opposite effects on DC
commitment compared to general MSCs, however. Sca1+
MSCs are important components of the niche (Morikawa
et al., 2009). Our study demonstrates that a much higher
number of DC phenotype cells is induced by Sca1+ MSCs,
supporting the MSC subpopulation being involved in DC
commitment. These results provide a novel way to probe
more MSC subsets, such as CD146+, CD166+, CD271+, or
nestin+ cells, in the process of myeloid lineage maturation
and especially DC differentiation in the future.
The STAT3 and STAT5 genes play a central role in
controlling cell proliferation, differentiation, migration,
and apoptosis. The STAT3 molecule regulates the
proliferation and/or maintenance of the Flt3+ progenitor
population, thereby controlling the production of DCs;
pDC and cDC numbers are reduced in STAT3-deﬁcient
bone-marrow cultures (Laouar et al., 2003). The STAT5
gene was important for cDC development from lin-Flt3+
progenitors triggered by GM-CSF (Esashi et al., 2008). As
STAT3 is a potential target of the caspase family (AbdulGhani and Megeney, 2008), the function of the caspase
family in regulating cell proliferation has also been
considered. In this study, we found that the caspase-3

mRNA level increased and the STAT3 and STAT5 mRNA
levels decreased in the Sca1+ group; thus, we postulated
that Sca1+ MSCs are involved in DC commitment via
STAT3/STAT5 and caspase-3 molecules. Further studies
are needed to explore how STAT3/STAT5 and caspase-3
interact with each other, however.
DCs play a crucial role in the innate and adaptive
immune responses. Upon being challenged by antigens,
DCs activate and migrate into lymphoid organs to
present antigen peptides, before initiating adaptive
immune responses (Ganguly et al., 2013). However, the
way in which the immune responses are inhibited by
MSCs remains unclear (Frenette et al., 2013). Herein, the
Sca1+ MSCs promoted the presentation of costimulatory
molecules CD80 and CD86 and the migration ability as
compared to MSCs in vivo and in vitro. This indicates
that the Sca1+ MSCs are an active MSC component that
indirectly regulates the activation and migration of DCs.
In summary, our data suggest that Sca1+ MSCs modulate
DC commitment, activation, and migration. The present
study aids in understanding the commitment of the
myeloid lineage in the niche.
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